PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 259 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $779 | +72.7% | 26,643 | +81.2% | 0.01% | +50.0% |
| Q3 2023 | $451 | -52.3% | 14,707 | -37.7% | 0.00% | -50.0% |
| Q2 2023 | $946 | -1.5% | 23,615 | +0.4% | 0.01% | 0.0% |
| Q1 2023 | $960 | -55.3% | 23,517 | -57.7% | 0.01% | -74.2% |
| Q4 2022 | $2,147 | -99.8% | 55,614 | +225.8% | 0.03% | +158.3% |
| Q2 2022 | $995,000 | +35.9% | 17,069 | +40.2% | 0.01% | -20.0% |
| Q3 2020 | $732,000 | -34.2% | 12,173 | -50.4% | 0.02% | -28.6% |
| Q4 2019 | $1,113,000 | +24.5% | 24,567 | +4.7% | 0.02% | -32.3% |
| Q3 2019 | $894,000 | -57.1% | 23,473 | -51.1% | 0.03% | -62.7% |
| Q2 2019 | $2,086,000 | +522.7% | 47,958 | +516.0% | 0.08% | +245.8% |
| Q4 2018 | $335,000 | – | 7,786 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |